Irvine, CA – March 25, 2025 – GATC Health Corp., a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, is pleased to share its recent feature on Becker’s Healthcare Podcast. In the episode titled “Revolutionizing Drug Discovery with AI: A Conversation with Dr. Rahul Gupta,” Dr. Rahul Gupta, President of GATC Health, […]
Read MoreMonth: March 2025
-
GATC Health Corp. Congratulates Advisory Board Member Dr. Richard Schatz on National Inventors Hall of Fame Induction
IRVINE, CA – March 13, 2025 – GATC Health Corp., a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, proudly congratulates Dr. Richard Schatz on his induction into the National Inventors Hall of Fame. Dr. Schatz, a distinguished cardiologist and a valued member of GATC Health’s advisory board, is being recognized for […]
Read More -
GATC Health Announces Expansion of West Virginia Lab, Strategic WVU Appointments, and Focus on AI Driven Drug Discovery
MORGANTOWN, WV, March 11, 2025 – GATC Health Corp., a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, today announced significant updates to its West Virginia lab, highlighting its commitment to innovation, regional collaboration, and addressing critical healthcare challenges. The expansion includes key appointments and a sharpened focus on leveraging artificial intelligence […]
Read More -
GATC Health’s Ian Jenkins Showcases AI-Driven Drug Discovery Breakthroughs at B. Riley Precision Oncology; Radiopharma Investor Conference
New York, NY – March 4, 2025 – GATC Health, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discovery, proudly announces that Ian Jenkins, Chief Scientific Officer, was a featured panelist at the prestigious B. Riley Precision Oncology & Radiopharma Investor Conference. Jenkins participated in the panel discussion, “AI-Driven Solutions Focused on […]
Read More